← All trials
NCT02011620
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2014
- Primary completion
- Dec 31, 2014
- Completion date
- Dec 31, 2014
- First posted
- Dec 13, 2013
- Last posted
- Sep 11, 2019
- Enrollment
- 0
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Tameside Hospital NHS Foundation TrustLead sponsor
- Tameside Hospital NHS Foundation TrustReponsible party - principal investigator
- Tameside Hospital NHS Foundation TrustSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.